MEDP
Get informed when a big investor buys or sells
+ FollowOvervalued by 8.8% based on the discounted cash flow analysis.
| Market cap | $17.08 Billion |
|---|---|
| Enterprise Value | $17.61 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $15.64 |
| Beta | 1.18 |
| Outstanding Shares | 28,308,000 |
| P/E Ratio | 35.2 |
|---|---|
| PEG | 102.14 |
| Price to Sales | 6.41 |
| Price to Book Ratio | 41.91 |
| Enterprise Value to Revenue | 6.33 |
| Enterprise Value to EBIT | 30.25 |
| Enterprise Value to Net Income | 35 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | 2.36 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 510.76% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Holdings and activity of institutional investors.
| Ownership % | 0.81%▼ 87.74% |
|---|---|
| Total Invested | $143.87M▼ 98.91% |
| Investors Holding | 22▼ 691.00% |
No data